Necrotic enteritis is a $6 billion problem for the chicken industry. It starts with a microbe that belongs there. Clostridium perfringens lives in every healthy chicken's gut. But when a bird gets stressed, from a feed change or a vaccination, it turns into a gut-punching parasite. It starts making two toxins that break open the gut lining and pull nutrients out for itself. On Sept 29, BiomEdit got @USDA approval for the first engineered microbe that engrafts in the gut and secretes an antibody to stop it. Not by killing C. perfringens, and not with an antibiotic. By neutralizing the toxins and stopping its mechanism of action in its tracks. That mechanism is where the $6 billion comes from, and it hits farmers three ways: - Feed conversion. Most birds don't die. They just absorb less of what they eat and need about 11% more feed per pound of meat. Feed is 65 to 75% of the cost of raising a broiler, so this hits the bottom line directly. - Weight. Birds with the subclinical form run about 12% lighter at market. - Mortality. In the worst cases, the birds die. So does it work? In a challenge study with Southern Poultry Research Group, mortality fell from 13.1% to 6.6%, a 48.7% reduction. Treated birds also converted feed better and gained more weight. Same 42 days, same feed bill, more chicken. The product is already in more than 35 million broilers across three major US producers. That data comes in around January 2027. It's also proof of concept. You can deliver a microbe, have it engraft, and have it make a therapeutic right where the disease is. This is just the first of many potential applications for BiomEdit's microbe engineering platform for drug delivery. Next up are rumen strains that cut methane, gut enzymes that break down inflammatory factors, and dogs with IBD, where an antibody made inside the gut can stay out of the rest of the body. Our correspondent @AaronBlotnick spoke with Aaron Schacht earlier this month to learn about what BiomEdit is building and where they see this technology going. Schacht's take: "We have an N of 1. If you think back to the first antibody that was ever made, this might be the same moment for this modality." Aaron Blotnick has the full story on our website, link in the comments.

@sensible_bio secured $47M in combined financing to scale cell-based mRNA design, screening and clinical-grade manufacturing. dealroom.co/news/159939-sens… Want to stay ahead in biotech? Subscribe to our newsletter for more 🧬 syntheticbiologysummit.com/?…

When the hen is the bioreactor, flock health is process control. Neion Bio engineers hens to make biologic drugs in their eggs. Now it is bringing in Barnwell Bio, whose founders come from COVID wastewater surveillance, to watch the health of its flocks. Subscribe to our newsletter and get the biggest biotech news straight to your inbox 🧬 syntheticbiologysummit.com/?… "Neion uses chickens to manufacture recombinant proteins. Barnwell provides the intelligence needed to understand and protect the health environment in which those chickens live," says Dimi Kellari, cofounder and CEO of Neion Bio Two #Manhattan biotechs, one unusual partnership. Visit the #SynBioBeta website to read the full article. synbiobeta.com/read/neion-bi…

@bigideaventures is accepting applications for its food-innovation accelerator and direct-investment pathways across food, agtech and sustainable materials. bigideaventures.com/apply-no… Want to stay ahead in biotech? Subscribe to our newsletter for more 🧬syntheticbiologysummit.com/?…

@SuntheticsML , @scrippsresearch and @UCLA are using a $19.5M NSF award to build an open-access, closed-loop autonomous chemistry lab. sunthetics.io/blog-posts/nsf… Want to stay ahead in biotech? Subscribe to our newsletter for more 🧬 syntheticbiologysummit.com/?…

Deisseroth, Hegemann and Nagel won the 2026 Nobel Medicine Prize for the discoveries behind light-gated ion channels and optogenetics. apnews.com/article/nobel-pri… Want to stay ahead in biotech? Subscribe to our newsletter for more 🧬 syntheticbiologysummit.com/?…

Xaira reports that X-Design produced progressable antibody leads in weeks, including an antagonist for a GPCR target that resisted prior discovery methods. xaira.com/news/de-novo-desig… Want to stay ahead in biotech? Subscribe to our newsletter for more 🧬 syntheticbiologysummit.com/?…

@CochranLab at @Stanford went looking for a peptide against one cancer target and found one that binds five. Its spinout @TwoStep has now raised $71.2 million and has FDA IND clearance to begin human trials TwoStep Therapeutics grew out of the Stanford labs of #NobelPrize laureate Carolyn Bertozzi and Jennifer Cochran, with oncologist Ronald Levy as a co-founder. Subscribe to our newsletter and get the biggest biotech news straight to your inbox 🧬 syntheticbiologysummit.com/?… Its targeting molecule, PIP, is 33 amino acids long. The lab was screening for a binder to one integrin. The peptide that kept winning binds five. "It was a serendipitous discovery." @CaitlynBioE , CEO and co-founder, TwoStep That breadth matters. A tumor needs to express only one of the five for the drug to find it. TwoStep just raised a $62.5M Series A and won FDA IND clearance for TS-104. Visit the SynBioBeta website to read the full article: synbiobeta.com/read/nobel-la…

@theEVERYcompany is expanding OvoPro with Huvepharma and ADM as precision fermentation moves from pilot capacity toward commercial manufacturing. linkedin.com/pulse/what-year… Want to stay ahead in biotech? Subscribe to our newsletter for more 🧬 syntheticbiologysummit.com/?…

PreferCo appointed Shakthi M. Nagappan as CMD as it builds an integrated precision-fermentation platform spanning strain engineering through scale-up. timesofindia.indiatimes.com/… Want to stay ahead in biotech? Subscribe to our newsletter for more 🧬 syntheticbiologysummit.com/?…

@LonzaGroup and @AsimovBio are combining LV Edge stable producer cells with process development and GMP manufacturing for scalable in vivo lentiviral vectors. asimov.com/news/lonza-and-as… Want to stay ahead in biotech? Subscribe to our newsletter for more 🧬 syntheticbiologysummit.com/?…

Biomay and @Synthego are linking cGMP mRNA, Cas9, plasmid, LNP and sgRNA capabilities to simplify manufacturing for CRISPR programs. contractpharma.com/breaking-… Want to stay ahead in biotech? Subscribe to our newsletter for more 🧬syntheticbiologysummit.com/?…

@ARPA_H is betting it can stop neurodegeneration at the first misfolded protein. Post Translational Medicines is part of one of the teams. The San Francisco startup is one of 7 industry partners on a team that won up to $51.7 million from ARPA-H's BIOGAMI program. It will use its Surveyor platform to measure protein states directly inside cells. Subscribe to our newsletter and get the biggest biotech news straight to your inbox 🧬 syntheticbiologysummit.com/?… Visit the SynBioBeta website to read the full article synbiobeta.com/read/post-tra…

@Ginkgo details an enzyme-engineering stack spanning ~6B genes, AI + physics design and autonomous labs, with reported >80x activity gains in one program. ginkgo.bio/press-releases/ne… Want to stay ahead in biotech? Subscribe to our newsletter for more 🧬 syntheticbiologysummit.com/?…

@SPRIND is offering up to €4.3M per team in a 38-month challenge to build AI-controlled microbial consortia for circular biomanufacturing. sprind.org/en/actions/challe… Want to stay ahead in biotech? Subscribe to our newsletter for more 🧬syntheticbiologysummit.com/?…

@GoogleDeepMind introduced SynthID Bio, a proof-of-concept watermark designed to remain detectable in AI-generated protein sequences and structures. deepmind.google/blog/introdu… Want to stay ahead in biotech? Subscribe to our newsletter for more 🧬syntheticbiologysummit.com/?…

An @IDTechEx -backed analysis argues that bio-based feedstocks and biomanufacturing are not the same — and their economics and carbon profiles can differ sharply. plasticstoday.com/materials/… Want to stay ahead in biotech? Subscribe to our newsletter for more 🧬syntheticbiologysummit.com/?…

@EdisonSci and Population Health Partners report that Kosmos can compress IND preparation and protocol work from months toward weeks. edisonscientific.com/news/ho… Want to stay ahead in biotech? Subscribe to our newsletter for more 🧬syntheticbiologysummit.com/?…

@ProfluentBio and @BioMarin are pairing generative protein models with enzyme-therapy expertise to design and experimentally screen new therapeutic enzymes. businesswire.com/news/home/2… Want to stay ahead in biotech? Subscribe to our newsletter for more 🧬syntheticbiologysummit.com/?…

@Zymofix is investing €6M in a Belgian solid-state fermentation plant targeting 300 tonnes/year of microbial production from Q4 2027. htgf.de/en/zymofix-to-build-… Want to stay ahead in biotech? Subscribe to our newsletter for more 🧬 syntheticbiologysummit.com/?…

@schmidtsciences named eight 2026 Polymaths, committing up to $20M total and as much as $2.5M per researcher for cross-disciplinary science. schmidtsciences.org/2026-pol… Want to stay ahead in biotech? Subscribe to our newsletter for more 🧬syntheticbiologysummit.com/?…

Cytotrait appointed former Syngenta R&D leader Ian Jepson to its board as it expands its MOSS organelle-editing platform and crop-trait programs. businesswire.com/news/home/2… Want to stay ahead in biotech? Subscribe to our newsletter for more 🧬syntheticbiologysummit.com/?…

BiomEdit received USDA conditional licensure for CPerf LLV, an engineered probiotic biologic targeting necrotic enteritis in broiler chickens. prnewswire.com/news-releases… Want to stay ahead in biotech? Subscribe to our newsletter for more 🧬 ttps://www.syntheticbiologysummit.com/?utm_source=x&utm_medium=social&utm_campaign=digest&utm_content=text-link

A Work in Progress analysis argues that U.S. regulatory fragmentation has slowed deployment of engineered and Wolbachia mosquito-control technologies. worksinprogress.co/issue/mos… Want to stay ahead in biotech? Subscribe to our newsletter for more 🧬syntheticbiologysummit.com/?…

@Ginkgo Datapoints and @apheris_AI launched a 10,000-antibody developability consortium with @abbvie , @argenxglobal , @LundbeckUS and @TakedaPharma. businesswire.com/news/home/2… Want to stay ahead in biotech? Subscribe to our newsletter for more 🧬syntheticbiologysummit.com/?…

@Amoremall_JP and @junevity are pairing RESET’s AI-driven gene-network discovery with skin science to identify new pathways for skin rejuvenation. junevity.com/news/press-rele… Want to stay ahead in biotech? Subscribe to our newsletter for more 🧬 syntheticbiologysummit.com/?…

@MSFTResearch introduced Quine, an experimental multimodal biology system linking AI predictions with scientific tools and wet-lab validation. microsoft.com/en-us/research… Want to stay ahead in biotech? Subscribe to our newsletter for more 🧬 syntheticbiologysummit.com/?…

@BeamTx alleges a former scientist used trade secrets to help build a rival @yoltech gene-editing program for AATD. The claims are unproven. news.bloomberglaw.com/us-law… Want to stay ahead in biotech? Subscribe to our newsletter for more 🧬 syntheticbiologysummit.com/?…

@phylo_bio's Target Atlas brings continuously updated, source-linked target evidence into Biomni Lab, including a public MJFF Parkinson’s dashboard. phylo.bio/blog/target-atlas-… Want to stay ahead in biotech? Subscribe to our newsletter for more 🧬 synbiobeta.com/

@futurefieldsHQ’s $8M Series A is scaling its EntoEngine platform, which turns transgenic fruit flies into bioreactors for difficult-to-express proteins. pharmaceuticalonline.com/doc… Subscribe to our newsletter and get the biggest biotech news straight to your inbox 🧬 syntheticbiologysummit.com/?…

@AnthropicAI’s IPO filing shows 2025 revenue near $4.6B, operating losses around $8.1B, and $7.33B spent on compute and infrastructure — a sharp look at the economics of frontier AI. reuters.com/business/finance… Subscribe to our newsletter and get the biggest biotech news straight to your inbox 🧬 syntheticbiologysummit.com/?…

@novonordisk licensed HRS-1596 from Hengrui Pharma in a deal worth up to $2.6B. The phase 1-ready GLP-1/GIP dual agonist is designed for potential once-weekly oral dosing. novonordisk.com/content/nnco… Subscribe to our newsletter and get the biggest biotech news straight to your inbox 🧬 syntheticbiologysummit.com/?…

A new ACS review maps metabolic-engineering strategies for tobacco aroma, health-related traits, functionality and combustion by targeting pathways controlling terpenoids, alkaloids and other metabolites. pubs.acs.org/aastgj/article-… Subscribe to our newsletter and get the biggest biotech news straight to your inbox 🧬 syntheticbiologysummit.com/?…

@SaphoBio joined @nvidia Inception to advance an automation-first QC lab combining robotic sample prep, instrument-connected data and digital workflows for pharmaceutical release testing. saphobio.com/news/sapho-bio-… Subscribe to our newsletter and get the biggest biotech news straight to your inbox 🧬 syntheticbiologysummit.com/?…

The Alzheimer’s Association’s Part the Cloud initiative awarded nearly $7M across five translational programs, including combination therapies, repurposed drugs and its first AI-designed antibody project. alz.org/news/2026/part-the-c… Subscribe to our newsletter and get the biggest biotech news straight to your inbox 🧬 syntheticbiologysummit.com/?…

Eclipse Ingredients is preparing a 2027 launch for precision-fermented human lactoferrin, starting in cosmetics before expanding into adult nutrition and eventually infant formula. agfundernews.com/%f0%9f%8e%a… Subscribe to our newsletter and get the biggest biotech news straight to your inbox 🧬 syntheticbiologysummit.com/?…

Red Queen Bio is using AI to pre-design antibody candidates against plausible future pathogens, aiming to give the biosecurity response a faster starting point if a novel threat emerges. wsj.com/health/this-startup-… Subscribe to our newsletter and get the biggest biotech news straight to your inbox 🧬 syntheticbiologysummit.com/?…

@Roche says it has started building autonomous AI-driven labs as it expands computational tools across drug R&D, with AI already contributing to a growing share of pipeline decisions. reuters.com/business/healthc… Subscribe to our newsletter and get the biggest biotech news straight to your inbox 🧬 syntheticbiologysummit.com/?…

ADM is investing $55.5M to convert an underused Iowa facility into a precision fermentation operation for higher-value proteins and enzymes across food, feed and industrial markets. worldbiomarketinsights.com/a… Subscribe to our newsletter and get the biggest biotech news straight to your inbox 🧬 syntheticbiologysummit.com/?…

A bipartisan group of U.S. lawmakers introduced bills directing DHS and CISA to strengthen cyber and critical-infrastructure protections for biotech, biomanufacturing and sensitive biological data. cyberscoop.com/biotech-criti… Subscribe to our newsletter and get the biggest biotech news straight to your inbox 🧬 syntheticbiologysummit.com/?…

@OneSkinTech new Rich Cream combines its OS-01 longevity peptide with @C16Bio's fermentation-derived Palmless Torula Oil, bringing two biotech ingredient platforms into one formulation. linkedin.com/posts/palmless-… Subscribe to our newsletter and get the biggest biotech news straight to your inbox 🧬 syntheticbiologysummit.com/?…

Pilgrim raised $25M to develop a roughly 50-pound system for detecting airborne viruses and other biological threats, targeting the sensing layer of biosecurity. wsj.com/tech/ai/anthropic-le… Subscribe to our newsletter and get the biggest biotech news straight to your inbox 🧬 syntheticbiologysummit.com/?…

@BioDelivera is positioning GCV as a one-step, multi-payload delivery platform for directing therapies to hard-to-reach tissues across oncology, autoimmune disease and CNS applications. biodelivera.com/ Subscribe to our newsletter and get the biggest biotech news straight to your inbox 🧬 syntheticbiologysummit.com/?…

Sculpta put the barcode on the RNA itself, and splicing stops disappearing from drug screens. Subscribe to our newsletter and get the biggest biotech news straight to your inbox 🧬 syntheticbiologysummit.com/?… Nearly 25 times more splice junctions than DRUG-seq, per the preprint. "Setting up hundreds of individual reverse transcription and PCR reactions for qPCR has always felt absurd and anachronistic to me." The deals start with a conversation. SynBioBeta 2027, May 3 to 5, San Jose. Visit the SynBioBeta website to read the full article. synbiobeta.com/read/sculpta-…

Biographica and Hudson River Biotechnology are linking AI-driven gene-target discovery with editing, transformation and regeneration to take difficult crop traits from prediction to plants. agfundernews.com/bring-us-yo… Subscribe to our newsletter and get the biggest biotech news straight to your inbox 🧬 syntheticbiologysummit.com/?…

Precision Neuroscience raised $250M after 100+ patient procedures across 18 institutions, bringing total funding to $430M as its Layer 7 BCI advances toward commercialization. globenewswire.com/news-relea… Subscribe to our newsletter and get the biggest biotech news straight to your inbox 🧬 syntheticbiologysummit.com/?…

ABEC opened a 50,000-sq-ft Wilson, North Carolina facility with an ISO-7 cleanroom, expanding U.S. capacity for bioprocess equipment and single-use manufacturing components. biobuzz.io/news/abecs-wilson… Subscribe to our newsletter and get the biggest biotech news straight to your inbox 🧬 syntheticbiologysummit.com/?…

Boost VC is offering $50K Fellowship Checks to help very early frontier-tech founders turn ambitious deep-tech ideas into enough evidence for the next stage of company building. boost.vc/fellowship Subscribe to our newsletter and get the biggest biotech news straight to your inbox 🧬 syntheticbiologysummit.com/?…

Experiment Foundation opened $75K in Living Thresholds – Oceans microgrants to test whether biological variation can improve ecological forecasts built around temperature, pH, oxygen, and other fixed thresholds. experiment.com/programs/livi… Subscribe to our newsletter and get the biggest biotech news straight to your inbox 🧬 syntheticbiologysummit.com/?…

DOE @jgi's new strategy puts AI, machine-learning-ready genomic data, automation and connected research infrastructure at the center of predictive biology over the next five-plus years. jgi.doe.gov/user-science/sci… Subscribe to our newsletter and get the biggest biotech news straight to your inbox 🧬 syntheticbiologysummit.com/?…